关注
Dina Bugybayeva
标题
引用次数
引用次数
年份
A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model
D Bugybayeva, Z Kydyrbayev, N Zinina, N Assanzhanova, ...
Infectious Diseases of Poverty 10 (01), 56-65, 2021
172021
A split influenza vaccine formulated with a combination adjuvant composed of alpha-d-glucan nanoparticles and a STING agonist elicits cross-protective immunity …
V Patil, JF Hernandez-Franco, G Yadagiri, D Bugybayeva, S Dolatyabi, ...
Journal of Nanobiotechnology 20 (1), 477, 2022
122022
An orf-virus (ORFV)-based vector expressing a consensus H1 hemagglutinin provides protection against diverse swine influenza viruses
GM do Nascimento, D Bugybayeva, V Patil, J Schrock, G Yadagiri, ...
Viruses 15 (4), 994, 2023
102023
Development of human vectored brucellosis vaccine formulation: assessment of safety and protectiveness of influenza viral vectors expressing Brucella immunodominant proteins in …
D Bugybayeva, S Ryskeldinova, N Zinina, M Sarmykova, ...
BioMed Research International 2020 (1), 1438928, 2020
82020
Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies
S Ryskeldinova, N Zinina, Z Kydyrbayev, B Yespembetov, Y Kozhamkulov, ...
Frontiers in cellular and infection microbiology 11, 669196, 2021
52021
Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with …
JF Hernandez-Franco, G Yadagiri, V Patil, D Bugybayeva, S Dolatyabi, ...
Vaccines 11 (11), 1699, 2023
22023
Correction: A split influenza vaccine formulated with a combination adjuvant composed of alpha-D-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs
V Patil, JF Hernandez-Franco, G Yadagiri, D Bugybayeva, S Dolatyabi, ...
Journal of Nanobiotechnology 20, 2022
22022
Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs
V Patil, JF Hernandez-Franco, G Yadagiri, D Bugybayeva, S Dolatyabi, ...
Vaccines 11 (11), 1707, 2023
12023
Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose–Chitosan Nanoparticle-Based Intranasal Vaccine in Swine
D Bugybayeva, E Dumkliang, V Patil, G Yadagiri, R Suresh, M Singh, ...
Vaccines 12 (6), 647, 2024
2024
Characterization of a novel functional porcine CD3+ CD4lowCD8α+ CD8β+ T-helper/memory lymphocyte subset in the respiratory tract lymphoid tissues of swine influenza A virus …
V Patil, G Yadagiri, D Bugybayeva, J Schrock, R Suresh, ...
Veterinary Immunology and Immunopathology, 110785, 2024
2024
Evaluation of surface coated versus entrapped mannose-chitosan nanoparticle based intranasal inactivated vaccine against influenza A virus in swine
D Bugybayeva
The Ohio State University, 2023
2023
Plant derived Nano-11 particle adsorbed with stimulator of interferon genes adjuvant and split influenza virus antigens elicits the cross-protective immunity in pigs
RJ Gourapura, V Patil, JF Hernandez-Franco, G Yadaigiri, D Bugybayeva, ...
The Journal of Immunology 208 (1_Supplement), 124.12-124.12, 2022
2022
O5-1 Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies
S Ryskeldinova, N Zinina, Z Kydyrbayev, B Yespembetov, Y Kozhamkulov, ...
Brucellosis 2022 International Research Conference, 2022
2022
A new candidate vaccine for human brucellosis based on influenza viral vectors: development of immunization schedule in guinea pig model
D Bugybayeva, Z Kydyrbayev, N Zinina, N Assanzhanova, ...
2020
Safety of a new intranasal vaccine against equine influenza: a study of the stability of the ts ca phenotype of the reassortant strain in a natural host
N Assanzhanova, S Ryskeldinova, E Kozhamkulov, D Bugybayeva, ...
Adv. Anim. Vet. Sci 8 (12), 1356-1361, 2020
2020
TOWARDS NEW HUMAN BRUCELLOSIS VACCINE: SELECTING IMMUNIZATION MODALITY
DA Bugybayeva, SZ Ryskeldinova, ZK Kydyrbayev, YM Kozhamkulov, ...
Медицина (Алматы), 35-40, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–16